Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Dominick J Angiolillo

Showing results (131-140 of 760) with videos related to

Pageof 76
Sort By:
Expert Opinion on Pharmacotherapy|July 24, 2024
The pharmacology of antiplatelet agents for primary, secondary, and tertiary prevention of ischemic strokeClaudio Laudani, Davide Capodanno, Dominick J Angiolillo
Expert Opinion on Drug Metabolism & Toxicology|October 18, 2023
Evaluating the pharmacokinetic and pharmacodynamic impact of different modes of ticagrelor administrationMarco Spagnolo, Dominick J Angiolillo, Davide Capodanno
Thrombosis and Haemostasis|January 1, 2019
The Conundrum Surrounding Racial Differences on Ischaemic and Bleeding Risk with Dual Anti-Platelet TherapyAntonio Greco, Davide Capodanno, Dominick J Angiolillo
Expert Review of Cardiovascular Therapy|February 9, 2010
Mechanism of action and clinical development of ticagrelor, a novel platelet ADP P2Y12 receptor antagonistDavide Capodanno, Kodlipet Dharmashankar, Dominick J Angiolillo
Frontiers in Cardiovascular Medicine|March 20, 2023
Editorial: Precision medicine for antithrombotic therapy in patients after percutaneous coronary interventionsMattia Galli, Francesco Costa, Dominick J Angiolillo
JACC. Cardiovascular Interventions|March 26, 2025
Platelet-Fibrin Clot Strength for Risk Stratification After PCI in Patients With Diabetes Mellitus: Finding the Sweet SpotGiovanni Occhipinti, Salvatore Brugaletta, Dominick J Angiolillo
Nature Reviews. Cardiology|August 19, 2015
Switching P2Y12-receptor inhibitors in patients with coronary artery diseaseFabiana Rollini, Francesco Franchi, Dominick J Angiolillo
European Heart Journal. Cardiovascular Pharmacotherapy|January 25, 2024
Aspirin hypersensitivity and intoleranceMattia Galli, Giovanni Occhipinti, Dominick J Angiolillo
Thrombosis and Haemostasis|June 9, 2017
Antithrombotic therapy for acute coronary syndrome: Past, present and futureDirk Sibbing, Dominick J Angiolillo, Kurt Huber
Giornale Italiano Di Cardiologia (2006)|May 13, 2011
[Antiplatelet and anticoagulant therapy in elderly patients]Davide Capodanno, Dominick J Angiolillo, Corrado Tamburino
Pageof 76

Showing results (131-140 of 760) with videos related to

Sort By:
Pageof 76
Expert Opinion on Pharmacotherapy|July 24, 2024
The pharmacology of antiplatelet agents for primary, secondary, and tertiary prevention of ischemic strokeClaudio Laudani, Davide Capodanno, Dominick J Angiolillo
Expert Opinion on Drug Metabolism & Toxicology|October 18, 2023
Evaluating the pharmacokinetic and pharmacodynamic impact of different modes of ticagrelor administrationMarco Spagnolo, Dominick J Angiolillo, Davide Capodanno
Thrombosis and Haemostasis|January 1, 2019
The Conundrum Surrounding Racial Differences on Ischaemic and Bleeding Risk with Dual Anti-Platelet TherapyAntonio Greco, Davide Capodanno, Dominick J Angiolillo
Expert Review of Cardiovascular Therapy|February 9, 2010
Mechanism of action and clinical development of ticagrelor, a novel platelet ADP P2Y12 receptor antagonistDavide Capodanno, Kodlipet Dharmashankar, Dominick J Angiolillo
Frontiers in Cardiovascular Medicine|March 20, 2023
Editorial: Precision medicine for antithrombotic therapy in patients after percutaneous coronary interventionsMattia Galli, Francesco Costa, Dominick J Angiolillo
JACC. Cardiovascular Interventions|March 26, 2025
Platelet-Fibrin Clot Strength for Risk Stratification After PCI in Patients With Diabetes Mellitus: Finding the Sweet SpotGiovanni Occhipinti, Salvatore Brugaletta, Dominick J Angiolillo
Nature Reviews. Cardiology|August 19, 2015
Switching P2Y12-receptor inhibitors in patients with coronary artery diseaseFabiana Rollini, Francesco Franchi, Dominick J Angiolillo
European Heart Journal. Cardiovascular Pharmacotherapy|January 25, 2024
Aspirin hypersensitivity and intoleranceMattia Galli, Giovanni Occhipinti, Dominick J Angiolillo
Thrombosis and Haemostasis|June 9, 2017
Antithrombotic therapy for acute coronary syndrome: Past, present and futureDirk Sibbing, Dominick J Angiolillo, Kurt Huber
Giornale Italiano Di Cardiologia (2006)|May 13, 2011
[Antiplatelet and anticoagulant therapy in elderly patients]Davide Capodanno, Dominick J Angiolillo, Corrado Tamburino
Pageof 76